PER 1.01% 10.0¢ percheron therapeutics limited

In other news, Santhera had a meeting with FDA and was...

  1. 90 Posts.
    lightbulb Created with Sketch. 20
    In other news, Santhera had a meeting with FDA and was encouraged to apply for NDA for Vamorolone in DMD. NDA will start in 2022.
    https://www.s*nth*r*.de/assets/files/press-releases/2021-11-17_FDA-preNDA_d_final.pdf
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
0.001(1.01%)
Mkt cap ! $90.15M
Open High Low Value Volume
10.0¢ 10.0¢ 10.0¢ $112.6K 1.126M

Buyers (Bids)

No. Vol. Price($)
1 73873 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 225958 5
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.